1. Home
  2. OZ vs INBX Comparison

OZ vs INBX Comparison

Compare OZ & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OZ
  • INBX
  • Stock Information
  • Founded
  • OZ 2020
  • INBX 2010
  • Country
  • OZ United States
  • INBX United States
  • Employees
  • OZ N/A
  • INBX N/A
  • Industry
  • OZ
  • INBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OZ
  • INBX Health Care
  • Exchange
  • OZ Nasdaq
  • INBX Nasdaq
  • Market Cap
  • OZ 239.8M
  • INBX 178.5M
  • IPO Year
  • OZ N/A
  • INBX 2020
  • Fundamental
  • Price
  • OZ N/A
  • INBX $16.33
  • Analyst Decision
  • OZ
  • INBX Hold
  • Analyst Count
  • OZ 0
  • INBX 1
  • Target Price
  • OZ N/A
  • INBX N/A
  • AVG Volume (30 Days)
  • OZ 1.7K
  • INBX 84.1K
  • Earning Date
  • OZ 01-01-0001
  • INBX 08-12-2025
  • Dividend Yield
  • OZ N/A
  • INBX N/A
  • EPS Growth
  • OZ N/A
  • INBX N/A
  • EPS
  • OZ N/A
  • INBX 111.58
  • Revenue
  • OZ $4,077,000.00
  • INBX $200,000.00
  • Revenue This Year
  • OZ N/A
  • INBX N/A
  • Revenue Next Year
  • OZ N/A
  • INBX N/A
  • P/E Ratio
  • OZ N/A
  • INBX $0.15
  • Revenue Growth
  • OZ 94.70
  • INBX N/A
  • 52 Week Low
  • OZ $56.77
  • INBX $10.80
  • 52 Week High
  • OZ $82.89
  • INBX $17.79
  • Technical
  • Relative Strength Index (RSI)
  • OZ 51.30
  • INBX 68.23
  • Support Level
  • OZ $65.58
  • INBX $13.97
  • Resistance Level
  • OZ $66.24
  • INBX $15.25
  • Average True Range (ATR)
  • OZ 0.42
  • INBX 0.75
  • MACD
  • OZ -0.01
  • INBX 0.06
  • Stochastic Oscillator
  • OZ 53.01
  • INBX 99.16

About OZ Belpointe PREP LLC Units

Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: